• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

AGI chief joins XP advisory board

Freeport, N.Y. - Daniel B. Yarosh, Ph.D., president and CEOof AGI Dermatics, has been named to the Xeroderma PigmentosumSociety's Scientific Advisory Board.

Freeport, N.Y. - Daniel B. Yarosh, Ph.D., president and CEO of AGI Dermatics, has been named to the Xeroderma Pigmentosum Society's Scientific Advisory Board.

An acclaimed molecular biologist who has devoted 20 years to studying the effects of sun on DNA and skin, Dr. Yarosh is the inventor of Dimericine. This first therapeutic DNA repair enzyme can reduce the incidence of pre-cancers and basal cell carcinoma. Dimericine is currently in clinical testing for Food and Drug Administration approval as a topical prescription drug.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
© 2025 MJH Life Sciences

All rights reserved.